Bortezomib

tumor necrosis factor ; Mus musculus







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32221318 Nanosized Alumina Particle and Proteasome Inhibitor Bortezomib Prevented inflammation and Osteolysis Induced by Titanium Particle via Autophagy and NF-κB Signaling. 2020 Mar 27 1
2 30914235 Inhibitory effects of bortezomib in a subcutaneous tumor model of H22 mouse hepatocarcinoma cells. 2019 Jun 1
3 29773987 Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma. 2018 1
4 28487944 Bortezomib protects against dextran sulfate sodium‑induced ulcerative colitis in mice. 2017 Jun 1
5 28800777 Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity. 2017 Aug 11 1
6 24406455 Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model. 2014 Mar 3
7 24530998 TNF-α-mediated JNK activation in the dorsal root ganglion neurons contributes to Bortezomib-induced peripheral neuropathy. 2014 May 4
8 24022788 Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target. 2013 Dec 1
9 22427154 Inhibition of titanium particle-induced inflammation by the proteasome inhibitor bortezomib in murine macrophage-like RAW 264.7 cells. 2012 Aug 1
10 21360496 Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis. 2011 Mar 1
11 18539902 Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation. 2008 Aug 15 1
12 17328981 Proteasomal inhibition in intracerebral hemorrhage: neuroprotective and anti-inflammatory effects of bortezomib. 2007 May 1
13 17373661 TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response. 2007 Jul 15 6
14 16397116 Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5'-deoxy-5-fluorouridine in breast cancer cells. 2006 Apr 1
15 16585569 Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade). 2006 Apr 15 1
16 16670342 Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors. 2006 May 15 4